<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01612416</url>
  </required_header>
  <id_info>
    <org_study_id>TOTM 021</org_study_id>
    <nct_id>NCT01612416</nct_id>
  </id_info>
  <brief_title>Spectral Domain Optical Coherence Tomography Analysis for Glaucoma</brief_title>
  <official_title>Comparison of Ganglion Cell and Retinal Nerve Fiber Layer Thickness in Primary Open Angle Glaucoma and Normal Tension Glaucoma With Spectral Domain OCT</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Inonu University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Inonu University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to examine whether there is a difference in macular ganglion cell&#xD;
      complex thickness and retinal nerve fiber layer thickness in early-stage Primary open angle&#xD;
      glaucoma and normal tension glaucoma with spectral domain OCT.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Glaucoma is a progressive optic neuropathy characterized by gradual degeneration of neuronal&#xD;
      tissue in which retinal ganglion cells (RGCs) are injured, leading to the loss of the visual&#xD;
      field.Recent studies have separately demonstrated a reduction in the macular retinal&#xD;
      thickness and in the retinal nerve fibers in both POAG and NTG.It has been demonstrated that&#xD;
      in early stage NTG macular GCC thickness showed a strong correlation with thickness of the&#xD;
      RNFL. However there have yet to be any reports regarding the comparison of macular thickness,&#xD;
      ganglion cell complex and retinal nerve fiber layer between POAG and NTG with RS-3000&#xD;
      RetinaScan at early stage.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ganglion cell complex, retinal nerve fiber layer and retinal thickness measurements of glaucoma patients using spectral domain OCT.</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">169</enrollment>
  <condition>GLAUCOMA 1, OPEN ANGLE, D (Disorder)</condition>
  <arm_group>
    <arm_group_label>Normal subjects</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Primary open angle glaucoma</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal tension glaucoma</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>RS-3000 OCT measurements</intervention_name>
    <description>Ganglion cell, retinal nerve fiber layer and retinal thickness measurements of normal subjects, primary open angle glaucoma and normal tension glaucoma patients using RS-3000 OCT RetinaScan</description>
    <arm_group_label>Normal subjects</arm_group_label>
    <arm_group_label>Normal tension glaucoma</arm_group_label>
    <arm_group_label>Primary open angle glaucoma</arm_group_label>
    <other_name>GCC and RNFL in Open Angle and Normal Tension Glaucoma.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        The POAG group inclusion criteria were;&#xD;
&#xD;
          -  IOP higher than 21 mmHg before treatment on three different visits,&#xD;
&#xD;
          -  Best corrected VA of 20/25 or better with a spherical equivalent within ±5 D and a&#xD;
             cylinder correction within +3 D;&#xD;
&#xD;
          -  An open angle confirmed by gonioscopy.&#xD;
&#xD;
          -  Glaucomatous optic disc damage defined as by the presence of glaucomatous optic&#xD;
             neuropathy like rim thinning (diffuse or local), cupping, notching, and a cup/disc&#xD;
             ratio &gt;0.2 with asymmetry.&#xD;
&#xD;
        NTG group were included if;&#xD;
&#xD;
        • They had the same optic disc and visual field criteria as for the POAG patients with the&#xD;
        exception that their IOP was as ≤21 mmHg on three separate visits without any glaucomatous&#xD;
        treatment.&#xD;
&#xD;
        The control group&#xD;
&#xD;
          -  Who had no ocular disease&#xD;
&#xD;
          -  Who had not undergone ocular surgery or laser procedures.&#xD;
&#xD;
          -  With a normal anterior segment, open angles, and normal posterior segment findings&#xD;
             also normal optic nerve head appearance in their ophthalmic examination.&#xD;
&#xD;
          -  The IOP measurements were lower than 21 mmHg, and full-threshold 30-2 HFA were also&#xD;
             within normal limits in the control group.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subjects with any retinal disease, diabetes mellitus, or neurological disease or who&#xD;
             had undergone ocular surgery and laser procedures.&#xD;
&#xD;
          -  Subjects with pseudoexfoliation glaucoma and pigmentary glaucoma were excluded.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>28 Years</minimum_age>
    <maximum_age>72 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Penpe G Firat, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Assistant Professor</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Selim Doganay, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professor</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ersan E Demirel, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Resident</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cemil Colka, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Associate Professor</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Inonu University School of Medicine</name>
      <address>
        <city>Malatya</city>
        <zip>44280</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Ojima T, Tanabe T, Hangai M, Yu S, Morishita S, Yoshimura N. Measurement of retinal nerve fiber layer thickness and macular volume for glaucoma detection using optical coherence tomography. Jpn J Ophthalmol. 2007 May-Jun;51(3):197-203. Epub 2007 Jun 7.</citation>
    <PMID>17554482</PMID>
  </reference>
  <verification_date>June 2012</verification_date>
  <study_first_submitted>May 31, 2012</study_first_submitted>
  <study_first_submitted_qc>June 3, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 5, 2012</study_first_posted>
  <last_update_submitted>June 3, 2012</last_update_submitted>
  <last_update_submitted_qc>June 3, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 5, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Inonu University</investigator_affiliation>
    <investigator_full_name>Penpe Gul Firat</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Ganglion Cell complex, Retinal Nerve Fiber Layer,Glaucoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

